ChiCTR-OCS-13003773
正在进行
/
/
/
2013-11-11
/
/
Valvular Heart Disease
亞洲心臟瓣膜病前瞻性登記冊
亞洲心臟瓣膜病前瞻性登記冊
亞洲心臟瓣膜病前瞻性登記冊
单臂
其它
NA
/
Division of Cardiology, Department of Medicine and Therapeutics
/
300
/
2013-11-06
1990-01-01
/
a) Patients with significant MR or AS (≥mild); b) Patients with organic MR or AS; c) Patients able to undergo a comprehensive echocardiographic evaluation; d) The patient or the guardian gives written informed consent before participating the study; e) The patient is willing to give full information on his/her medical history, including the drugs.;
登录查看a) Patient with functional (for example, ischemic MR) MR; b) Patient with concomitant valvular heart disease other than MR or AS; c) Patient with other concomitant congenital heart disease.;
登录查看NO
/
diabetes 埃诺格鲁肽 SLIMMER
医药笔记2025-06-22
遗传性血管性水肿 III期 BD项目
美柏资本2025-06-22
ADA GIPR PCSK9
信达生物2025-06-22
diabetes 埃诺格鲁肽 内分泌学
先为达生物2025-06-22
PDL1 三阴性乳腺癌 atezolizumab
BioArtMED2025-06-21
EGFR 结直肠癌 JMT101
石药集团2025-06-21
糖尿病 GLP-1/GIP
恒瑞医药2025-06-21
肥胖 Wegovy
一度医药2025-06-21